Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Oksana Tsinman"'
Publikováno v:
ADMET and DMPK (2022)
The intake of food and meal type can strongly impact the bioavailability of orally administered drugs and can consequently impact drug efficacy and safety. During the early stages of drug development, only a small amount of drug substance is availabl
Externí odkaz:
https://doaj.org/article/8f1aab6dd3394470a0fbce1a47255c19
Autor:
Szabina Kádár, Petra Tőzsér, Brigitta Nagy, Attila Farkas, Zsombor K. Nagy, Oksana Tsinman, Konstantin Tsinman, Dóra Csicsák, Gergely Völgyi, Krisztina Takács-Novák, Enikő Borbás, Bálint Sinkó
Publikováno v:
The AAPS Journal. 24
The work aimed to develop the Absorption Driven Drug Formulation (ADDF) concept, which is a new approach in formulation development to ensure that the drug product meets the expected absorption rate. The concept is built on the solubility-permeabilit
Autor:
Szabina, Kádár, Petra, Tőzsér, Brigitta, Nagy, Attila, Farkas, Zsombor K, Nagy, Oksana, Tsinman, Konstantin, Tsinman, Dóra, Csicsák, Gergely, Völgyi, Krisztina, Takács-Novák, Enikő, Borbás, Bálint, Sinkó
Publikováno v:
The AAPS journal. 24(1)
The work aimed to develop the Absorption Driven Drug Formulation (ADDF) concept, which is a new approach in formulation development to ensure that the drug product meets the expected absorption rate. The concept is built on the solubility-permeabilit
Autor:
Gergely Völgyi, Hajnalka Pataki, Enikő Borbás, Bálint Sinkó, Konstantin Tsinman, Krisztina Takács-Novák, Oksana Tsinman, Dóra Csicsák, Szabina Kádár
Publikováno v:
Molecular Pharmaceutics. 16:4121-4130
In this work, two different approaches have been developed to predict the food effect and the bioequivalence of marketed itraconazole (ITRA) formulations. Kinetic solubility and simultaneous dissolution-permeation tests of three (ITRA) formulations (
Autor:
Konstantin Tsinman, Oksana Tsinman, Enikő Borbás, Bálint Sinkó, Krisztina Takács-Novák, Petra Tőzsér, Zsombor Kristóf Nagy, Gergely Völgyi
Publikováno v:
Molecular Pharmaceutics. 15:3308-3317
The aim of this research was to investigate the driving force of membrane transport through size-exclusion membranes and to provide a concentration-based mathematical description of it to evaluate whether it can be an alternative for lipophilic membr
Autor:
Bernard Van Eerdenbrugh, Bernd Ulrich Riebesehl, Arnaud Grandeury, Oksana Tsinman, Saijie Zhu, Konstantin Tsinman, Michael Juhnke, Ram Lingamaneni
Publikováno v:
Pharmaceutical Research. 35
The goal of the study was to evaluate a miniaturized dissolution-permeation apparatus (μFLUX™ apparatus) for its ability to benchmark several itraconazole (ITZ) formulations for which in vivo PK data was available in the literature. Untreated and
Publikováno v:
AAPS PharmSciTech. 19(7)
This study described a pH-gradient dissolution method combined with flux measurements as an in vitro tool for assessing the risk of bioavailability reduction due to drug-drug interactions (DDI) caused by acid reducing agents (ARAs). The device incorp
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 114:88-96
The extent of ionization of a drug molecule at different pH values can be characterized by its pKa (acid dissociation constants). It is an important parameter in pharmaceutical development to rationalize the physiochemical and biopharmaceutical prope
Autor:
Bálint Sinkó, Balázs Farkas, Attila Balogh, Konstantin Tsinman, Oksana Tsinman, Brigitta Nagy, Zsombor Kristóf Nagy, Enikő Borbás
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 114
In this study, brand and four generic formulations of telmisartan, an antihypertensive drug, were used in in vitro simultaneous dissolution-absorption, investigating the effect of different formulation additives on dissolution and on absorption throu
Autor:
Alex Avdeef, Oksana Tsinman
Publikováno v:
Pharmaceutical Research. 25:2613-2627
The objective was to investigate the feasibility of using a miniaturized disk intrinsic dissolution rate (IDR) apparatus to determine the Biopharmaceutics Classification System (BCS) solubility class, and to develop an approach where IDR measurements